Stocks

USFDA clearance may lift Strides Pharma

| Updated on August 09, 2019 Published on August 10, 2019

 

Strides Pharma Science on Friday said its Alathur facility in Chennai has completed inspection by the US health regulator with zero observations.

The facility underwent US Food and Drug Authority inspection from August 5-9, Strides Pharma said, and added it recently completed a significant capacity expansion programme that will support its growth momentum for the US business, besides solving near-term capacity issues due to the ongoing remediation at the Puducherry facility.

Published on August 10, 2019
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.